Medicaments Containing Hormones or Steroids
Código 300490 (Harmonized System 2012 by 6 digits)
2023: US$5.04B, Total Trade Exchange
2023: US$1.57B, International Sales
2023: US$3.47B, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Medicaments Containing Hormones or Steroids was US$5.04B.
In 2023, the states with the most international sales in Medicaments Containing Hormones or Steroids were Ciudad de México (US$962M), Estado de México (US$155M), Jalisco (US$151M), Baja California (US$45.9M), and Chihuahua (US$9.96M).
The states with the most international purchases in 2023 were Ciudad de México (US$2.74B), Estado de México (US$483M), Jalisco (US$74.5M), Morelos (US$60.9M), and Chihuahua (US$45.4M).
In 2023, the main commercial destinations of Medicaments Containing Hormones or Steroids were United States (US$488M), Canada (US$192M), Colombia (US$105M), Brazil (US$102M), and Panama (US$73.5M).
The main commercial origins of Medicaments Containing Hormones or Steroids in 2023 were Germany (US$727M), United States (US$482M), Ireland (US$244M), Italy (US$236M), and Puerto Rico (US$223M).
In the global context, the main exporting countries of Medicaments Containing Hormones or Steroids in 2022 were Germany (US$63.8B), Switzerland (US$38.9B), and United States (US$37.1B). In the same year, the main importing countries of Medicaments Containing Hormones or Steroids were United States (US$68.4B), Germany (US$28.5B), and Switzerland (US$26.6B).
Trade Balance of Mexico
#permalink to sectionNet Trade Balance
#permalink to sectionUS$5.04B, Total Trade Exchange (2023)
In 2023, the total trade exchange of Medicaments Containing Hormones or Steroids in Mexico (including international purchases and sales) was US$5.04B.
The visualizations show the net balance of Medicaments Containing Hormones or Steroids at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Net International Trade
#permalink to sectionNovember, 2024
- US$277M, International Purchases
- US$205M, International Sales
In November 2024, international sales of Medicaments Containing Hormones or Steroids were US$205M, while international purchases reached US$277M. The above results in a trade balance of -US$72.4M.
Market Concentration
#permalink to section2024-Q4: US$304M, International Sales
The visualization shows the quarterly concentration of international sales of Medicaments Containing Hormones or Steroids at state level.
In the fourth quarter of 2024, international sales were US$304M, being the states with the most sales Ciudad de México (US$241M), Jalisco (US$29.2M), and Estado de México (US$22.7M).
Exchange by Territory
#permalink to sectionInternational Sales
#permalink to sectionCiudad de México: US$962M, State with the Most International Sales (2023)
United States: US$488M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Medicaments Containing Hormones or Steroids were Ciudad de México (US$962M), Estado de México (US$155M), Jalisco (US$151M), Baja California (US$45.9M), and Chihuahua (US$9.96M).
In 2023, the countries with the most international purchases from Mexico were United States (US$488M), Canada (US$192M), Colombia (US$105M), Brazil (US$102M), and Panama (US$73.5M).
International Purchases
#permalink to sectionCiudad de México: US$2.74B, State with the Most International Purchases (2023)
Germany: US$727M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Medicaments Containing Hormones or Steroids were Ciudad de México (US$2.74B), Estado de México (US$483M), Jalisco (US$74.5M), Morelos (US$60.9M), and Chihuahua (US$45.4M).
The countries with the most international sales to Mexico in 2023 were Germany (US$727M), United States (US$482M), Ireland (US$244M), Italy (US$236M), and Puerto Rico (US$223M).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Medicaments Containing Hormones or Steroids and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Medicaments Containing Hormones or Steroids. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.35%, Mexican share in global exports - 2022
- 0.6%, Mexican share in global imports - 2022
The visualizations show the global market for Medicaments Containing Hormones or Steroids. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Medicaments Containing Hormones or Steroids were Germany (US$63.8B), Switzerland (US$38.9B), and United States (US$37.1B). In the same year, the main importing countries for Medicaments Containing Hormones or Steroids were United States (US$68.4B), Germany (US$28.5B), and Switzerland (US$26.6B).